Abbott Laboratories stock pre-market at EUR 89.14: plus 0.48 percent
Published on 09/30/2026 at 07:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Abbott Laboratories stock was at EUR 89.14 pre-market at 7:53 a.m. CEST on September 30, 2026, according to Lang & Schwarz. That was a plus 0.48 percent change versus the EUR 88.71 prior close at Lang & Schwarz.
Previous session reference
The prior close at Lang & Schwarz was EUR 88.71 on September 29, 2026. Abbott Laboratories trades on the New York Stock Exchange under the ticker ABT.
Infant-formula legal case
A September 15, 2026 report by Yahoo Finance said Abbott Laboratories had agreed to a settlement resolving U.S. Justice Department allegations involving infant-formula production and regulatory compliance. The report said the settlement resolved civil claims without an admission of wrongdoing or a finding of liability, while a related criminal investigation had been closed.
New Similac product
In an August 31, 2026 report, Yahoo Finance reported that Abbott launched Similac 360 Total Care Made With Whole Milk in the United States. The ready-to-feed liquid infant formula uses whole milk and a blend of human milk oligosaccharides.
